DE69005950D1 - Zweiwertige Metallsalze von 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophensäure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. - Google Patents
Zweiwertige Metallsalze von 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophensäure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.Info
- Publication number
- DE69005950D1 DE69005950D1 DE90402401T DE69005950T DE69005950D1 DE 69005950 D1 DE69005950 D1 DE 69005950D1 DE 90402401 T DE90402401 T DE 90402401T DE 69005950 T DE69005950 T DE 69005950T DE 69005950 D1 DE69005950 D1 DE 69005950D1
- Authority
- DE
- Germany
- Prior art keywords
- carboxymethyl
- cyano
- amino
- metal salts
- divalent metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8911475A FR2651497B1 (fr) | 1989-09-01 | 1989-09-01 | Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69005950D1 true DE69005950D1 (de) | 1994-02-24 |
DE69005950T2 DE69005950T2 (de) | 1994-07-21 |
Family
ID=9385063
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69005950T Expired - Lifetime DE69005950T2 (de) | 1989-09-01 | 1990-08-31 | Zweiwertige Metallsalze von 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophensäure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. |
DE200512000001 Active DE122005000001I2 (de) | 1989-09-01 | 1990-08-31 | Zweiwertige Metallsalze von 2-N, N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxy-thiophens{ure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE200512000001 Active DE122005000001I2 (de) | 1989-09-01 | 1990-08-31 | Zweiwertige Metallsalze von 2-N, N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxy-thiophens{ure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
Country Status (18)
Country | Link |
---|---|
US (1) | US5128367A (de) |
EP (1) | EP0415850B1 (de) |
JP (1) | JPH0692386B2 (de) |
AT (1) | ATE100093T1 (de) |
AU (1) | AU624022B2 (de) |
CA (1) | CA2024419C (de) |
DE (2) | DE69005950T2 (de) |
DK (1) | DK0415850T3 (de) |
ES (1) | ES2062450T4 (de) |
FR (1) | FR2651497B1 (de) |
HK (1) | HK57097A (de) |
IE (1) | IE65157B1 (de) |
LU (1) | LU91125I2 (de) |
NL (1) | NL300168I2 (de) |
NZ (1) | NZ234770A (de) |
OA (1) | OA09463A (de) |
PT (1) | PT95184B (de) |
ZA (1) | ZA906716B (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7404967B2 (en) * | 1994-12-21 | 2008-07-29 | Cosmederm, Inc. | Topical product formulations containing strontium for reducing skin irritation |
FR2749759B1 (fr) * | 1996-06-17 | 1999-11-26 | Adir | Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose |
FR2844796A1 (fr) * | 2002-09-24 | 2004-03-26 | Servier Lab | Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates |
FR2844797B1 (fr) | 2002-09-24 | 2004-10-22 | Servier Lab | Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates |
FR2844795B1 (fr) * | 2002-09-24 | 2004-10-22 | Servier Lab | Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates |
FR2846558B1 (fr) * | 2002-11-05 | 2006-07-14 | Servier Lab | Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales |
EP1534305B9 (de) | 2003-05-07 | 2007-03-07 | Osteologix A/S | Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen |
CA2524610C (en) | 2003-05-07 | 2014-03-25 | Osteologix A/S | Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions |
WO2004098617A2 (en) * | 2003-05-07 | 2004-11-18 | Osteologix A/S | Controlled release composition containing a strontium salt |
US6905723B2 (en) * | 2003-05-30 | 2005-06-14 | Depuy Products, Inc. | Strontium-substituted apatite coating |
US20050085531A1 (en) * | 2003-10-03 | 2005-04-21 | Hodge Carl N. | Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
CA2557324C (en) | 2004-02-26 | 2012-10-16 | Osteologix A/S | Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
JP4954867B2 (ja) * | 2004-05-06 | 2012-06-20 | オステオロジックス エイ/エス | 有機金属塩類を製造するための高収率で迅速な合成法 |
DK1768748T4 (da) | 2004-06-25 | 2019-06-11 | Mokwalo Spf S A | Sammensætninger omfattende strontium og vitamin D og anvendelser deraf |
FR2875807B1 (fr) | 2004-09-30 | 2006-11-17 | Servier Lab | Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
CN100391955C (zh) * | 2005-04-30 | 2008-06-04 | 河北医科大学 | 一种雷尼酸锶中间体的合成方法 |
CA2619720A1 (en) * | 2005-08-19 | 2007-02-22 | Glenmark Pharmaceuticals Limited | Process for the preparation of strontium ranelate |
FR2899895B1 (fr) * | 2006-04-12 | 2010-09-17 | Servier Lab | Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US20070292535A1 (en) * | 2006-06-19 | 2007-12-20 | Tabbiner Philip S | Strontium compositions and methods of treating arthritic and or osteoporitic conditions |
US20070292529A1 (en) * | 2006-06-19 | 2007-12-20 | Tabbiner Philip S | Strontium compositions and methods of treating osteoporotic conditions |
CN101229154B (zh) * | 2007-01-26 | 2010-05-12 | 鲁南制药集团股份有限公司 | 治疗骨质疏松的药物组合物 |
FR2921367B1 (fr) * | 2007-09-26 | 2009-10-30 | Servier Lab | Nouveau procede de synthese du ranelate de strontium et de ses hydrates |
US20120123131A1 (en) * | 2008-08-22 | 2012-05-17 | Koilpillai Joseph Prabahar | Process for the preparation of strontium ranelate |
EP2346846A1 (de) | 2008-09-29 | 2011-07-27 | Ratiopharm GmbH | Anhydrat- und hydratformen von strontiumranelat |
CN101747316B (zh) * | 2008-12-12 | 2013-09-25 | 重庆医药工业研究院有限责任公司 | 高纯度的雷奈酸锶及其制备方法 |
EP2416756A2 (de) | 2009-04-10 | 2012-02-15 | Mahmut Bilgic | Stabile pharmazeutische zusammensetzungen mit hoher bioverfügbarkeit |
FR2953139B1 (fr) | 2009-11-27 | 2012-04-13 | Servier Lab | Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine |
CN101775002B (zh) * | 2009-12-23 | 2015-07-15 | 浙江华海药业股份有限公司 | 一种制备雷尼酸锶的方法 |
HU228820B1 (en) | 2010-01-14 | 2013-05-28 | Richter Gedeon Nyrt | Process for the preparation of distrontium ranelate |
IT1398542B1 (it) * | 2010-03-05 | 2013-03-01 | Chemelectiva S R L | Processo per la preparazione di un polimorfo |
WO2011110597A1 (de) | 2010-03-11 | 2011-09-15 | Azad Pharmaceutical Ingredients Ag | Verfahren zur herstellung von strontiumranelat |
WO2011124992A1 (en) | 2010-03-24 | 2011-10-13 | Actavis Group Ptc Ehf | Substantially pure strontium ranelate |
CN102241663B (zh) * | 2010-05-10 | 2013-02-13 | 山东方明药业集团股份有限公司 | 一种雷奈酸锶八水合物的制备方法 |
WO2012046251A2 (en) * | 2010-10-08 | 2012-04-12 | Glenmark Generics Limited | Novel form of ranelic acid |
CN102180864B (zh) * | 2011-03-28 | 2012-12-12 | 中国药科大学 | 一种雷尼酸锶的制备方法 |
CZ2011320A3 (cs) | 2011-05-30 | 2012-12-12 | Zentiva, K.S. | Stabilní krystalická forma X stroncium ranelátu |
EP2530068A1 (de) | 2011-05-31 | 2012-12-05 | Lacer, S.A. | Neue Strontiumsalze, deren Synthese und Verwendung bei der Behandlung von Osteoporose |
WO2013013003A1 (en) | 2011-07-21 | 2013-01-24 | Emory University | Methods for treating inflamatory conditions and states, and cancers by antagonizing nf-kb activation |
CN102503931A (zh) * | 2011-09-20 | 2012-06-20 | 浙江华海药业股份有限公司 | 一种雷尼酸锶晶形h的制备方法 |
WO2013113319A1 (en) | 2012-01-31 | 2013-08-08 | Pharmathen S.A. | Process for the preparation of strontium ranelate, intermediate or hydrates thereof |
EP2641905A1 (de) | 2012-03-23 | 2013-09-25 | Urquima S.A. | Feste Formen von Strontiumranelat und Verfahren zu ihrer Herstellung |
US8569514B1 (en) | 2012-05-17 | 2013-10-29 | Divi's Laboratories, Ltd. | Process for the preparation of strontium ranelate |
CN103804345B (zh) * | 2013-09-06 | 2017-03-15 | 精华制药集团股份有限公司 | 一种用hplc法中控制备高纯度雷尼酸锶的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3905577A1 (de) * | 1989-02-23 | 1990-08-30 | Basf Ag | Diaminothiophene |
-
1989
- 1989-09-01 FR FR8911475A patent/FR2651497B1/fr not_active Expired - Lifetime
-
1990
- 1990-08-03 NZ NZ234770A patent/NZ234770A/xx unknown
- 1990-08-23 ZA ZA906716A patent/ZA906716B/xx unknown
- 1990-08-31 CA CA002024419A patent/CA2024419C/fr not_active Expired - Lifetime
- 1990-08-31 OA OA59850A patent/OA09463A/xx unknown
- 1990-08-31 PT PT95184A patent/PT95184B/pt not_active IP Right Cessation
- 1990-08-31 DK DK90402401.5T patent/DK0415850T3/da active
- 1990-08-31 EP EP90402401A patent/EP0415850B1/de not_active Expired - Lifetime
- 1990-08-31 AU AU62033/90A patent/AU624022B2/en not_active Expired
- 1990-08-31 US US07/576,225 patent/US5128367A/en not_active Expired - Lifetime
- 1990-08-31 AT AT90402401T patent/ATE100093T1/de active
- 1990-08-31 JP JP2232271A patent/JPH0692386B2/ja not_active Expired - Lifetime
- 1990-08-31 IE IE316290A patent/IE65157B1/en not_active IP Right Cessation
- 1990-08-31 DE DE69005950T patent/DE69005950T2/de not_active Expired - Lifetime
- 1990-08-31 ES ES90402401T patent/ES2062450T4/es not_active Expired - Lifetime
- 1990-08-31 DE DE200512000001 patent/DE122005000001I2/de active Active
-
1997
- 1997-05-01 HK HK57097A patent/HK57097A/xx not_active IP Right Cessation
-
2004
- 2004-12-15 LU LU91125C patent/LU91125I2/fr unknown
- 2004-12-24 NL NL300168C patent/NL300168I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
NL300168I1 (nl) | 2005-03-01 |
AU6203390A (en) | 1991-03-07 |
US5128367A (en) | 1992-07-07 |
IE903162A1 (en) | 1991-03-13 |
ATE100093T1 (de) | 1994-01-15 |
NZ234770A (en) | 1991-11-26 |
PT95184A (pt) | 1991-05-22 |
JPH03169876A (ja) | 1991-07-23 |
EP0415850A1 (de) | 1991-03-06 |
JPH0692386B2 (ja) | 1994-11-16 |
PT95184B (pt) | 1997-06-30 |
LU91125I2 (fr) | 2005-02-15 |
CA2024419C (fr) | 1999-07-20 |
OA09463A (fr) | 1992-11-15 |
ZA906716B (en) | 1991-06-26 |
DK0415850T3 (da) | 1994-03-21 |
DE122005000001I2 (de) | 2006-02-09 |
HK57097A (en) | 1997-05-09 |
ES2062450T4 (es) | 2011-12-29 |
NL300168I2 (nl) | 2005-03-01 |
DE122005000001I1 (de) | 2005-05-12 |
FR2651497A1 (fr) | 1991-03-08 |
ES2062450T3 (es) | 1994-12-16 |
IE65157B1 (en) | 1995-10-04 |
DE69005950T2 (de) | 1994-07-21 |
FR2651497B1 (fr) | 1991-10-25 |
EP0415850B1 (de) | 1994-01-12 |
CA2024419A1 (fr) | 1991-03-02 |
AU624022B2 (en) | 1992-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69005950D1 (de) | Zweiwertige Metallsalze von 2-N,N-di(carboxymethyl)amino,3-cyano,4-carboxymethyl,5-carboxy-thiophensäure, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. | |
DE68923819D1 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
DK0418339T3 (da) | Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv | |
DE3265898D1 (en) | Process for the industrial preparation of collagenous materials from human placental tissues; human collagenous materials obtained and their use in biomaterials | |
DE19775096I2 (de) | Desulfatohirudine Verfahren zu ihrer Herstellung und pharmazeutische Mittel | |
DE69029186D1 (de) | 3-Indolbrenztraubensäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung | |
DE69118081D1 (de) | Hyaluronsäurenatriumsalz und Desinfektionsmittel enthaltende pharmazeutische Zusammensetzungen zur äusserlichen Anwendung | |
ATE84716T1 (de) | 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten. | |
ES2044170T3 (es) | Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen. | |
DE59004380D1 (de) | Verfahren zur Herstellung von alpha-Fluoracrylsäurederivaten und neue 1,1-Difluor-2-halogenethyl-(halogen) methyl-ketone. | |
PT86776A (pt) | Process for the preparation of piperazinecarboxylic acid and pharmaceutical compositions containing it | |
ATE91612T1 (de) | Verfahren zur vorbereitunng der beseitigung eines artikulationsfehlers an einem bezahnten menschlichen kiefer eines patienten. | |
DE59200566D1 (de) | Aryl-Chinolyl-substituierte 1,4-Dihydropyridin-dicarbonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln. | |
ATE59035T1 (de) | Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel. | |
IL97110A0 (en) | Benzylphosphonic acid derivatives,compositions containing them and their use in treating viral diseases | |
ES2191825T3 (es) | Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia. | |
ATE12649T1 (de) | Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate. | |
PT85524A (de) | Oxiran-pseudooligosaccharide verfahren zu deren herstellung de ren verwendung und pharmazeutische praeparate | |
DK417889D0 (da) | Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme | |
DE69031409D1 (de) | 8-Carboxy-1,2,3,4-tetrahydroquinolin-6-yl-essigsäure und Verfahren zu dessen Herstellung | |
DE59003806D1 (de) | Zubereitung eines salzes von oxypurinol in oraler form zur behandlung von hyperuricämie. | |
IT8520736A0 (it) | Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari. | |
ATE46360T1 (de) | Plasminogenaktivator fuer menschliches gewebe, diesen aktivator enthaltende pharmazeutische zusammensetzungen, verfahren zur herstellung des aktivators sowie dna und transformierte zellzwischenprodukte hierfuer. | |
IT1223005B (it) | Autoclave perfezionata per la sterilizzazione di oggetti e strumenti in particolare per uso medico e chirurgico | |
IT8609534A0 (it) | Preparato,in particolare collirio o pomata,per il trattamento di alterazioni distrofiche e vascolari dei tessuti oculari. |